SEC Tracker
Get the app

CRISPR Therapeutics CRSP

CRISPR Therapeutics AG announced its financial results for the quarter ended June 30

Form
8-K
Filed
Importance
Routine
  • Reports quarterly results (2.02)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when CRISPR Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2836) and public float over $2B, nearest public float first, as each company reports it on its annual report cover.

  1. Adma Biologics ADMA public float $4.2B, Jun 30, 2025
  2. Halozyme Therapeutics HALO public float $4.5B, Jun 30, 2025
  3. Vaxcyte PCVX public float $3.7B, Jun 30, 2025
  4. Krystal Biotech KRYS public float $3.5B, Jun 30, 2025
  5. Arcellx ACLX public float $3.2B, Jun 30, 2025